Johnson & Johnson (NYSE:JNJ)
| 164.70 Delayed Data As of 4:00pm ET |  -1.66 / -1.00%Today’s Change | 155.72 Today|||52-Week Range 186.69 | -3.72% Year-to-Date |
Latest JNJ News | Press Releases
| The Best Value Stock to Buy for the Long Term 10:47am / StockNews.com - Paid Partner Content | Afraid of a Recession? Do These 4 Things Today Sep 28 / MotleyFool.com - Paid Partner Content |
| Is Johnson & Johnson a Buy? 10:37am / MotleyFool.com - Paid Partner Content | 3 Stocks That Can Power Through a Recession Sep 28 / StockNews.com - Paid Partner Content |
| Should Vanguard Value ETF (VTV) Be on Your Investing Radar? 6:20am / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T Sep 27 / Zacks.com - Paid Partner Content |
| 3 Reasons Why Cathie Wood Won't Touch This Warren Buffett Stock 5:20am / MotleyFool.com - Paid Partner Content | 1 Stock Living up to Its Name This Year Sep 27 / StockNews.com - Paid Partner Content |
| Band-Aids and Tylenol will have a new name on their packages 3:54am / CNN.com | Is iShares Core High Dividend ETF (HDV) a Strong ETF Right Now? Sep 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 166.36 |
| Today’s open | 165.99 |
| Day’s range | 163.89 - 167.16 |
| Volume | 7,008,265 |
| Average volume (3 months) | 7,113,466 |
| Market cap | $438.3B |
Data as of 4:00pm ET, 09/29/2022
Growth & Valuation
| Earnings growth (last year) | +41.93% |
| Earnings growth (this year) | +3.03% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +13.55% |
| P/E ratio | 24.0 |
| Price/Sales | 4.88 |
| Price/Book | 5.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| LLYEli Lilly and Co | -4.37 | -1.31% |
| ABBVAbbVie | -1.92 | -1.33% |
| PFEPfizer | -0.25 | -0.56% |
| MRKMerck | -0.08 | -0.09% |
Data as of 4:00pm ET, 09/29/2022
Financials
| Next reporting date | October 18, 2022 |
| EPS forecast (this quarter) | $2.53 |
| Annual revenue (last year) | $93.8B |
| Annual profit (last year) | $20.9B |
| Net profit margin | 22.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
